5.1 Patient Medical History, Systemic Disease Alerts & Vital Signs

5.1 Patient Medical History, Systemic Disease Alerts & Vital Signs

Patient assessment forms the clinical foundation of safe, effective dental care. Before any diagnostic exploration, dental imaging, local anesthetic administration, or operative treatment begins, the dental team must establish a thorough, legally binding record of the patient's past and current health status. Systemic physiological conditions directly affect oral health, dictate the safety of pharmacologic agents, and influence the body's response to surgical or restorative interventions. As an essential member of the dental healthcare team, the registered dental assistant plays a pivotal role in reviewing health records, identifying critical medical alerts, stratifying surgical risks, and measuring accurate baseline vital signs.

---

The Comprehensive Patient Medical History Record

The medical-dental health history is an indispensable clinical and legal record. It serves to protect the patient from life-threatening medical emergencies in the dental operatory and protects the dental practice from liability arising from preventable adverse drug reactions or systemic complications.

Intake Protocols and Legal Documentation Requirements

Every new patient must complete a comprehensive health history questionnaire prior to receiving clinical evaluation or care. The questionnaire gathers detailed information regarding:

• Systemic Diseases and Chronic Illnesses: Diagnosed cardiovascular disorders, endocrine conditions (diabetes mellitus, thyroid disease), respiratory illnesses (asthma, COPD), neurological deficits (epilepsy, stroke), hematologic disorders, kidney or liver disease, and infectious conditions (HIV/AIDS, hepatitis, active tuberculosis).
• Pharmacological Profile: All current prescription medications, over-the-counter (OTC) drugs, dietary supplements, herbal remedies, and daily dosages.
• Allergies and Sensitivities: Documented adverse reactions to medications (penicillin, sulfa drugs, local anesthetics, codeine, NSAIDs), environmental agents, foods, and materials commonly used in dentistry (latex, impression media, acrylic resins, nickel).
• Surgical and Hospitalization History: Recent surgeries, hospital admissions, organ transplants, artificial cardiac valves, and orthopedic prosthetic joints.
• Physician Contact Information: Primary care physicians, cardiologists, oncologists, or surgical specialists who may need to be consulted prior to treatment.

All paper records must be written in permanent black or blue ink. If an error occurs on a paper chart, never apply correction fluid, white-out, or black ink scribbles; draw a single horizontal line through the error, enter the corrected text above or adjacent, and initial and date the entry. In digital EHR systems, all modifications create an indelible electronic audit log that preserves prior entries and timestamps modifications.

---

ASA Physical Status Classification System

The American Society of Anesthesiologists (ASA) Physical Status Classification System is the universally accepted standard used by medical and dental clinicians to assess a patient's overall physical fitness and perioperative risk prior to administering local anesthesia, sedation, or surgical intervention.

Clinical Application of Stress Reduction Protocols

For patients classified as ASA II or ASA III due to cardiovascular disease, hypertension, or dental anxiety, the assistant coordinates a comprehensive stress reduction protocol:

1. Appointment Timing: Schedule appointments early in the morning when the patient is well-rested and endogenous cortisol levels are balanced.
2. Duration: Keep appointments brief (typically under 45 to 60 minutes) to prevent physical and emotional fatigue.
3. Vital Signs Baseline: Take and record blood pressure, pulse, and respiration prior to initiating treatment.
4. Pain Control: Ensure profound local anesthesia to eliminate intraoperative discomfort that could trigger endogenous adrenaline release.
5. Post-Operative Management: Provide clear instructions, adequate analgesic coverage, and a telephone check-in later that day.

---

Medical Alert Badges, Electronic Flags & High-Risk Conditions

When a patient's health history reveals a medical condition, allergy, or medication regimen that could trigger a medical emergency or alter treatment, a medical alert must be created.

Privacy Boundaries and Alert Placement

Under the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, patient medical details must never be exposed to public view:

• Paper Charts: Brightly colored "Medical Alert" stickers (red or fluorescent yellow) are affixed to the inside cover of the chart folder. Placing alert stickers on the outside of a chart folder visible to individuals walking through hallways or operatories violates federal privacy regulations.
• Electronic Health Records (EHR): High-priority electronic pop-up banners or alert icons (such as a red medical cross) display prominently on the operatory monitor once the patient's record is unlocked, immediately informing chairside clinicians of critical alerts.

Latex Hypersensitivity Protocols

Latex allergies range from mild Type IV delayed hypersensitivity (contact dermatitis causing redness, pruritus, and localized vesicle formation 24 to 48 hours post-exposure) to life-threatening Type I IgE-mediated immediate hypersensitivity, which can induce rapid urticaria, angioedema, bronchospasm, and fatal systemic anaphylaxis.

Bisphosphonate Therapy and Osteonecrosis Risks

Patients receiving antiresorptive or antiangiogenic medications—including oral bisphosphonates (such as alendronate/Fosamax, risedronate/Actonel) for osteoporosis or high-dose intravenous (IV) bisphosphonates (such as zoledronic acid/Zometa, pamidronate/Aredia) and the RANK-ligand inhibitor denosumab (Prolia for osteoporosis; Xgeva for bone metastases)—carry a significant risk of developing Medication-Related Osteonecrosis of the Jaw (MRONJ).

MRONJ presents as exposed, non-vital bone in the maxillofacial region that persists for longer than eight weeks in a patient with a history of antiresorptive therapy and no history of radiation therapy to the jaws. Invasive dental procedures that manipulate alveolar bone—including tooth extractions, periodontal flap surgery, and dental implant placement—are the primary precipitating events. Dental assistants must verify the drug name, route of administration (IV therapy carries vastly greater risk than oral therapy), duration of treatment, and ensure informed consent documentation highlights bone healing risks prior to any surgical consultation.

Anticoagulant and Antiplatelet Therapy Guidelines

Many dental patients take anticoagulant or antiplatelet medications to prevent thromboembolic events associated with atrial fibrillation, mechanical heart valves, deep vein thrombosis, pulmonary embolism, or coronary artery stents:

• Vitamin K Antagonists (Warfarin / Coumadin): Patients taking warfarin require monitoring via the International Normalized Ratio (INR). The normal baseline INR for an untreated individual is 1.0. For patients on therapeutic warfarin, the therapeutic target range is standardly 2.0 to 3.0 (or 2.5 to 3.5 for patients with mechanical heart valves). Most routine restorative care, scaling, and simple extractions can proceed when a recent INR (ideally from the past 24 hours, and no more than 72 hours old in a stable patient) is 3.5 or lower. Above 3.5, the dentist consults the physician before invasive surgery. Patients should never stop warfarin on their own.
• Direct Oral Anticoagulants (DOACs): Medications such as apixaban (Eliquis), rivaroxaban (Xarelto), and dabigatran (Pradaxa) inhibit specific clotting factors directly. They exhibit predictable pharmacokinetics and do not require routine INR blood monitoring.
• Antiplatelet Agents: Aspirin and clopidogrel (Plavix) prevent platelet aggregation. Patients taking these agents should generally never discontinue them prior to dental treatment without an explicit written directive from their prescribing cardiologist or physician, as discontinuing antiplatelet therapy dramatically elevates the risk of acute myocardial infarction or stroke.

To manage localized bleeding in patients taking anticoagulants, the assistant prepares local hemostatic agents: oxidized regenerated cellulose (Surgicel), absorbable gelatin sponges (Gelfoam), topical thrombin, tranexamic acid mouthwash, and sterile gauze for firm direct mechanical pressure.

Orthopedic Joint Replacement Premedication Guidelines

Historically, patients with prosthetic joint implants (total hip or knee replacements) were routinely prescribed antibiotic prophylaxis prior to dental visits. Current evidence-based guidelines from the American Dental Association (ADA) and the American Association of Orthopaedic Surgeons (AAOS) state that prophylactic antibiotics are not recommended prior to dental procedures for the vast majority of patients with prosthetic joint implants. Bacteremias arising from daily activities such as toothbrushing and mastication present far greater cumulative exposure than dental procedures. Antibiotic prophylaxis is only considered in rare, vulnerable patients who possess severe immunocompromise, previous prosthetic joint infection, or after formal consultation and directive from the patient's orthopedic surgeon.

Infective Endocarditis (IE) AHA Antibiotic Prophylaxis Guidelines

Infective endocarditis is a severe, potentially fatal infection of the heart valves or endocardium caused by circulating bacteremias that adhere to abnormal or prosthetic cardiovascular tissue. The American Heart Association (AHA) restricts antibiotic prophylaxis recommendations strictly to patients with the highest risk of adverse outcomes from IE.

Patient Indications for AHA Endocarditis Prophylaxis

Prophylactic premedication is recommended only for patients with the following specific cardiac conditions:

1. Prosthetic cardiac valves or prosthetic material used for cardiac valve repair.
2. Previous history of documented infective endocarditis.
3. Congenital Heart Disease (CHD):
   • Unrepaired cyanotic congenital heart disease, including palliative shunts and conduits.
   • Completely repaired congenital heart defect with prosthetic material or device during the first 6 months after the procedure.
   • Repaired congenital heart disease with residual defects at the site or adjacent to the site of a prosthetic patch or prosthetic device.
4. Cardiac transplant recipients who develop cardiac valvulopathy.

Dental Procedures Requiring Antibiotic Premedication

For patients meeting the above high-risk cardiac criteria, antibiotic prophylaxis is required for all dental procedures that involve:

• Manipulation of gingival tissue (e.g., periodontal scaling, probing, subgingival cord placement, prophylaxis).
• Manipulation of the periapical region of teeth (e.g., endodontic instrumentation, periapical surgery).
• Perforation of the oral mucosa (e.g., extractions, soft tissue biopsies, suture placement).

Prophylaxis is NOT required for routine local anesthetic injections through non-infected tissue, exposure of diagnostic dental radiographs, placement or adjustment of removable prosthodontic or orthodontic appliances, or the shedding of primary teeth.

If a patient inadvertently forgets to take their premedication prior to arriving at the dental office, the medication may be administered chairside prior to beginning the procedure. In the event that premedication was accidentally omitted entirely, the antibiotic may be administered up to 2 hours following the procedure.

---

Baseline Vital Signs Recording and Clinical Interpretation

Recording accurate baseline vital signs provides an objective snapshot of a patient's immediate physiologic status. Vital signs establish a baseline against which intraoperative changes or emergencies can be compared. The four standard vital signs are blood pressure (BP), pulse rate (P), respiration rate (R), and body temperature (T).

Blood Pressure Assessment and AHA Diagnostic Categories

Blood pressure measures the lateral force exerted by circulating blood against the walls of systemic arteries. It is recorded as two distinct numbers in millimeters of mercury (mm Hg):

• Systolic Blood Pressure (top number): The maximum pressure generated within the arterial system during ventricular contraction (systole).
• Diastolic Blood Pressure (bottom number): The resting pressure maintained within the arterial system during ventricular relaxation and cardiac refilling (diastole).

According to the American Heart Association (AHA) and American College of Cardiology (ACC) guidelines (the 2025 AHA/ACC update kept the 2017 categories), adult blood pressure is categorized as follows:

• Normal: Systolic < 120 mm Hg AND Diastolic < 80 mm Hg.
• Elevated: Systolic 120 to 129 mm Hg AND Diastolic < 80 mm Hg.
• Stage 1 Hypertension: Systolic 130 to 139 mm Hg OR Diastolic 80 to 89 mm Hg.
• Stage 2 Hypertension: Systolic >= 140 mm Hg OR Diastolic >= 90 mm Hg.
• Severe Hypertension: Systolic > 180 mm Hg AND/OR Diastolic > 120 mm Hg (older charts call this a hypertensive crisis; with chest pain, shortness of breath, neurologic signs, or vision changes it is a hypertensive emergency that needs 911). If a patient presents in this range without acute symptoms (chest pain, shortness of breath, blurred vision), wait five minutes and retest. If blood pressure remains above 180/120 mm Hg, elective dental treatment must be deferred immediately, and the patient must be referred for urgent medical intervention.

Sphygmomanometer Cuff Sizing and Technique Errors

Blood pressure is recorded using an aneroid or digital sphygmomanometer and a stethoscope. The assistant must position the patient seated upright with legs uncrossed, back supported, and the bare arm resting on a flat support at heart level.

Pulse Rate Assessment

The arterial pulse reflects the rhythmic expansion and recoil of an artery driven by the wave of blood ejected during left ventricular systole.

• Normal Resting Adult Pulse: 60 to 100 beats per minute (bpm).
• Tachycardia: A resting heart rate exceeding 100 bpm (may be caused by anxiety, caffeine, fever, exercise, dehydration, hyperthyroidism, or cardiac arrhythmias).
• Bradycardia: A resting heart rate below 60 bpm (commonly seen in well-conditioned athletes, but can indicate heart block, hypothyroidism, or medication side effects such as beta-blocker therapy).

Anatomical Sites for Pulse Palpation

• Radial Artery: Located on the anterior-lateral aspect of the wrist, immediately proximal to the base of the thumb. This is the standard site for routine dental baseline pulse recording. Palpate using the pads of the index and middle fingers; never use the thumb, as the thumb possesses its own prominent arterial pulse that can be mistaken for the patient's pulse. Count beats for 30 seconds and multiply by two; if the rhythm is irregular, count for a full 60 seconds.
• Carotid Artery: Located in the groove between the larynx (trachea) and the anterior border of the sternocleidomastoid muscle in the neck. This site is utilized during cardiovascular emergencies and cardiopulmonary resuscitation (CPR) because central carotid perfusion persists even when peripheral radial pulses collapse during profound shock.
• Brachial Artery: Located on the medial aspect of the antecubital fossa; primarily used for positioning the stethoscope during blood pressure auscultation and for assessing pulses in infants.

In addition to rate, the assistant evaluates rhythm (regular vs. irregular) and volume/amplitude (normal, bounding, or weak/thready).

Respiration Assessment

Respiration represents the external exchange of oxygen and carbon dioxide between the body and atmospheric air. One respiration cycle consists of one complete inspiration (inhalation) and one expiration (exhalation).

• Normal Resting Adult Respiration: 12 to 20 breaths per minute (rpm).
• Tachypnea: Abnormally rapid breathing exceeding 20 rpm (associated with hyperventilation, fever, respiratory distress, or severe anxiety).
• Bradypnea: Abnormally slow breathing below 12 rpm (associated with opioid use, central nervous system depression, or diabetic coma).

Body Temperature Assessment

Body temperature reflects the balance between heat produced by cellular metabolism and heat lost to the environment. The hypothalamic thermoregulatory center maintains human core temperature within a narrow physiological window.

• Normal Oral Baseline Temperature: 98.6°F (37.0°C), with an acceptable normal resting range of 97.6°F to 99.0°F (36.4°C to 37.2°C).
• Pyrexia (Fever): An oral temperature exceeding 100.4°F (38.0°C). In dental settings, an elevated temperature combined with localized oral pain, facial asymmetry, or trismus (inability to open the jaw) strongly suggests an acute, spreading odontogenic infection (cellulitis or fascial space abscess) requiring immediate intervention.